Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03365960 · ClinicalTrials.gov registry record · NA

Bioavailability and Pharmacokinetic Parameters of Watermelon (Rind, Flesh and Seeds) Polyphenols

A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT03365960 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03365960, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

The primary objectives of the study are outlined below: 1. To investigate the relative bioavailability and absorption/kinetic profile of polyphenols after consumption of watermelon rind, flesh and seeds, respectively in an acute pilot study. 2. To study the effects of watermelon intake on endothelial function using the FMD technique and to understand the relationship between plasma metabolites, including L-citrulline and arginine, and FMD responses.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Watermelon Rind
  • DIETARY_SUPPLEMENT Watermelon Flesh
  • DIETARY_SUPPLEMENT Watermelon Seeds

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2018-01-15
Est. Completion 2019-04-02
Phase NA

What the Registry Record Tells You About NCT03365960

The ClinicalTrials.gov registry entry for NCT03365960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT03365960 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03365960 about?

NCT03365960 is a clinical study titled "Bioavailability and Pharmacokinetic Parameters of Watermelon (Rind, Flesh and Seeds) Polyphenols". The primary objectives of the study are outlined below: 1. To investigate the relative bioavailability and absorption/kinetic profile of polyphenols after consumption of watermelon rind, flesh and seeds, respectively in an acute pilot study. 2. To study the effects of watermelon intake on endotheli...

What is the current status of trial NCT03365960?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2018-01-15. Estimated completion is 2019-04-02.

What interventions are being tested in trial NCT03365960?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Watermelon Rind (DIETARY_SUPPLEMENT), Watermelon Flesh (DIETARY_SUPPLEMENT), Watermelon Seeds (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03365960?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.